Targeted News Service logo

-- Preview Email Newsletter
Journals Biology Newsletter for 2026-06-30 ( 5 items )  
AACR Names Matthew Vander Heiden, MD, PhD, FAACR, as Editor-in-Chief of the Journal Cancer Discovery (10)
PHILADELPHIA, Pennsylvania, June 29 [Category: Medical] -- The American Association for Cancer Research posted the following news release: * * * AACR Names Matthew Vander Heiden, MD, PhD, FAACR, as Editor-in-Chief of the Journal Cancer Discovery * PHILADELPHIA - The American Association for Cancer Research (AACR) today announced the appointment of Matthew Vander Heiden, MD, PhD, Fellow of the AACR Academy (FAACR), as editor-in-chief of Cancer Discovery, one of the 10 highly esteemed journals published by AACR. Vander Heiden will serve as ed more PR

Efzimfotase Alfa Demonstrated Improvements in Bone Health in Treatment-Naive Pediatric Patients With Hypophosphatasia Achieving Median Difference of 1.67 vs. Placebo in RGI-C Score at Week 25 in MULBERRY Phase III Trial (10)
WILMINGTON, Delaware, June 30 -- AstraZeneca, a biopharmaceutical company, issued the following news release: * * * Efzimfotase alfa demonstrated improvements in bone health in treatment-naIve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial Efzimfotase alfa demonstrated favorable safety profile and tolerability in treatment -naive patients and those switching from STRENSIQ(R) across largest Phase III clinical program in HPP including MULBERRY, CHEST more PR

Hope for Huntington's Disease (10)
WURZBURG, Germany, June 29 -- The University of Wurzburg issued the following news release: * * * Hope for Huntington's Disease * The hereditary disorder Huntington's disease has so far been considered incurable. Its clinical manifestations include impaired motor control and psychiatric symptoms. A new study offers promising insights. It shows that a specific drug candidate called anle138b can significantly reduce the toxic protein clumps in the brain that are characteristic of the disease. Affected mice that were administered this compou more PR

St. Olaf announces a new neuroscience major for incoming students (10)
NORTHFIELD, Minnesota, June 29 -- St. Olaf College issued the following news: * * * St. Olaf announces a new neuroscience major for incoming students * From understanding how memories are formed to exploring the biological basis of behavior, neuroscience seeks to answer some of the most fascinating questions about what makes us human. As discoveries in neuroscience continue to transform medicine, technology, education, and mental health, interest in the field has grown rapidly among St. Olaf College students. Starting in the fall of 2026, more PR

Two Longtime Georgetown University Medical Center Faculty Leaders Move to Emeritus Roles (10)
WASHINGTON, June 26 -- The Georgetown University Medical Center issued the following news: * * * Two Longtime Georgetown Faculty Leaders Move to Emeritus Roles Two longtime Georgetown University Medical Center faculty leaders -- Phyllis R. Magrab, PhD, and Richard Schlegel, MD, PhD -- are moving to emeritus roles after careers that have left an outsized imprint on the institution and the world. Together, they have contributed nearly 100 years to Georgetown, training generations of researchers and clinicians and producing scholarship with re more PR